Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ned Tijdschr Geneeskd ; 151(21): 1186-90, 2007 May 26.
Artigo em Holandês | MEDLINE | ID: mdl-17557759

RESUMO

A 68-year-old man was hospitalised with a vascular occlusion in the left leg. After treatment with urokinase he developed multiple intracerebral haemorrhages. The occlusion and the intracerebral haemorrhages evoked by urokinase were caused by embolisation originating from a cardiac metastasis of a renal-cell carcinoma. Cardiac surgery was performed, but complete removal of the tumour was not possible. The process of embolisation continued and the patient died a few weeks after diagnosis. Cardiac metastasis is seen in 10% of all cancer patients. Most of these metastases remain without symptoms. Left ventricular metastasis of renal-cell carcinoma without involvement of the inferior V. cava is very rare. If embolic occlusion of one or more vascular areas is present, transthoracic echography of the heart should be performed. Early detection and surgical treatment prevent further embolisation which may result in a better prognosis.


Assuntos
Carcinoma de Células Renais/secundário , Hemorragia Cerebral/etiologia , Neoplasias Cardíacas/secundário , Embolia Intracraniana/etiologia , Neoplasias Renais/patologia , Idoso , Carcinoma de Células Renais/complicações , Carcinoma de Células Renais/cirurgia , Evolução Fatal , Fibrinolíticos/efeitos adversos , Fibrinolíticos/uso terapêutico , Neoplasias Cardíacas/complicações , Neoplasias Cardíacas/cirurgia , Humanos , Masculino , Prognóstico , Ativador de Plasminogênio Tipo Uroquinase/efeitos adversos , Ativador de Plasminogênio Tipo Uroquinase/uso terapêutico
2.
Int J Stroke ; 2(4): 270-5, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18705927

RESUMO

BACKGROUND: Delirium is a complex neuropsychiatric syndrome characterized by disturbances of consciousness, attention, cognition, and perception. It may be the presenting feature of acute stroke, but more often it complicates the clinical course in the early stage of rehabilitation. SUMMARY OF REVIEW: Risk factors for delirium are older age, pre-existing cognitive decline, metabolic disturbances, infections, and polypharmacy. Recognition of delirium in patients with stroke is important because of its association with a longer stay in the hospital, a poor functional outcome, and an increased risk of developing dementia. The diagnosis may be difficult because of the fluctuating course and the neurological deficits that are caused by the stroke. Nonpharmacological preventive measures, early identification, and additional medical intervention are the key measures in the management of delirium after stroke. CONCLUSION: This review describes incidence, risk factors, pathophysiology, diagnostic tools, and management of delirium in patients with a recent stroke.


Assuntos
Delírio/etiologia , Acidente Vascular Cerebral/psicologia , Doença Aguda , Delírio/diagnóstico , Delírio/epidemiologia , Delírio/fisiopatologia , Delírio/terapia , Humanos , Prognóstico , Fatores de Risco , Índice de Gravidade de Doença
3.
J Neurol Neurosurg Psychiatry ; 73(6): 766-8, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12438488

RESUMO

BACKGROUND: Myasthenia gravis and the Lambert-Eaton myasthenic syndrome (LEMS) may have a similar distribution of muscle weakness. Deciding on a diagnosis of myasthenia gravis or LEMS on clinical grounds may therefore be difficult. OBJECTIVE: To compare the localisation of initial muscle weakness and the distribution of weakness at the time of maximum severity in patients with myasthenia gravis and LEMS. SUBJECTS: 101 patients with myasthenia gravis and 38 patients with LEMS. RESULTS: In myasthenia gravis, initial weakness involved extraocular muscles in 59%, bulbar muscles in 29%, and limb muscles in 12% of the patients. In LEMS no patient had ocular weakness, 5% had bulbar weakness, and 95% had weakness of the limbs as the first symptom (p < 0.001). At the point of maximum severity, weakness in myasthenia gravis was purely ocular in 25%, oculobulbar in 5%, restricted to the limbs in 2%, and present in both oculobulbar muscles and limbs in 68%. At this point, none of the LEMS patients had weakness restricted to extraocular or bulbar muscles (p = 0.002). The legs were affected in all LEMS patients, whereas in 12 patients with generalised myasthenia gravis limb weakness was restricted to the arms (p = 0.024). CONCLUSIONS: In a patient suspected to have a myasthenic syndrome whose first symptom is ocular weakness, LEMS is virtually excluded. Limb weakness confined to the arms is only found in generalised myasthenia gravis and not in LEMS. Muscle weakness in myasthenia gravis tends to develop in a craniocaudal direction, and in the opposite direction in LEMS.


Assuntos
Síndrome Miastênica de Lambert-Eaton/diagnóstico , Debilidade Muscular/diagnóstico , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Eletromiografia , Humanos , Pessoa de Meia-Idade , Países Baixos , Exame Neurológico , Músculos Oculomotores , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA